Rebif

Merck KGaA donates multiple sclerosis med Rebif to French COVID-19 trial
Fierce Pharma
Thu, 03/19/20 - 11:43 pm
Merck KGaA
COVID-19
Rebif
clinical trials
Merck KGaA bets on cancer drugs to revitalize German firm
Yahoo/Reuters
Mon, 10/12/15 - 09:16 am
Merck KGaA
cancer
Merck Serono
Rebif
Erbitux
Merck's Rebif held its own in last year's MS market shakeup. What about 2015?
Fierce Pharma
Tue, 03/3/15 - 01:27 pm
Rebif
MS
multiple sclerosis
Merck KGaA
Merck shores up Rebif defenses to fend off new MS rivals
Fierce Pharma
Thu, 03/6/14 - 11:34 am
Rebif
MS
multiple sclerosis
Merck KGaA
3 Blockbuster Drugs Losing Patent Protection in 2013's Final Months
Motley Fool
Fri, 11/1/13 - 08:38 am
patents
Amgen
Neupogen
Merck KGaA
Rebif
Cymbalta
Eli Lilly
2013 Should Be Interesting for Multiple Sclerosis Drugs
Motley Fool
Thu, 01/3/13 - 11:39 am
MS
multiple sclerosis
Teva
Copaxone
Rebif
Pfizer
Merck KGaA
Biogen Idec
Avonex
Bayer
Betaseron
Novartis
Extavia
Sanofi
Tysabri
Aubagio
Elan
Gilenya
BG-12
Sanofi Says MS Pill Aubagio Fails to Beat Rebif in Trial
Bloomberg
Tue, 12/20/11 - 10:23 am
Sanofi
MS
Aubagio
Rebif
multiple sclerosis
Merck KGaA
Merck Says Submits Application for MS Treatment Rebif in Europe
Bloomberg
Wed, 06/29/11 - 06:54 am
Merck
Rebif
MS
Europe
multiple sclerosis
Merck Serono pays $44M to settle kickback charge
Yahoo/AP
Wed, 05/4/11 - 08:44 pm
Merck Serono
settlements
kickbacks
Rebif
Biogen Idec and Elan plan Tysabri-comparison study
Marketwatch
Thu, 03/25/10 - 09:38 am
Elan
Biogen Idec
Tysabri
Rebif
Copaxone
Merck Serono
Teva Pharmaceuticals